Lupin completes acquisition of GAVIS
The combined company will have a portfolio of over 120 in-market products, over 185 cumulative filings pending approval and a deep…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Gavis Pharmaceuticals
Lupin, Gavis to sell two drugs to G&W Labs
The companies have agreed to sell rights and assets for two generic drugs to New Jersey-based G&W Laboratories in order to…